AccurEdit - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeAccurEdit
AccurEdit logo

AccurEdit

0 followers

About AccurEdit

AccurEdit is a biopharmaceutical company focused on advancing in vivo gene editing therapies. It operates in the field of genome editing medicine, with platforms and pipelines aimed at safe and targeted gene modification in humans, including systemic delivery and RNA synthesis workflows. The company highlights progress in China and the United States, pursuing regulatory recognition and clinical translation of its gene editing therapies.

Recent News

Recent Deals

No recent deals for this company.

Key Team Members

Claude Pumilia

Chief Executive Officer

Kevin Williams

Chief Revenue Officer

Martin Collinson

Chief Partnership Officer

Brian Wallace

Chief Marketing Officer

Trenton Pologar

Chief Information Officer

Key Facts

HQ Location

SuZhou, China

Founded

2021

Employees

11 - 50

Status

Private

Website

https://accuredit.com